CNBC’s Jim Cramer delivers his daily Mad Dash.

The parent of bankESB and TruNorth Bank will end its 157-year history as a depositor-owned institution, in part to fund the ...

Preview this article 1 min A Madrid, Spain-based cancer diagnostic firm seeks to grow its footprint to 21,000-square-foot at ...

Oral obesity drug with world-first mechanism of action unveiled, drawing strong on-site interestFollowing successful Phase 1 clinical results, global discussions on OVM-200 expandMeetings with over 40 ...

A Congressional investigation is looking into whether drug trials in China that involved U.S. companies possibly took place ...

Met a bulin, a Texas-based biotechnology company led by Hua Tu, PhD, is working to develop an ultra-stable insulin formulation that remains viable even at high temperatures. “Insulin instability has ...

Abivax Announces Closing of $920 Million Public Offering PARIS, France, July 6, 2026 –10:05 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a ...

Equity Insider News Commentary, The scramble to build a critical-minerals supply chain outside China has become one of the ...

Elicio Therapeutics, Inc. (Nasdaq: ELTX) ('Elicio” or the 'Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced the ...

Hospitals and health systems are rapidly adopting AI-powered tools, connected medical devices, advanced analytics and emerging biotechnology solutions. Most organizations evaluate these technologies ...

Gareth Soloway's technical market breakdown: S&P 500 trend-line test, semiconductor unwind, AI-to-biotech rotation, USD/JPY ...

In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...